Office of the Macau Special Administrative Region in Beijing

The FinOps Foundation Announces AIA as a Premier Member

Retrieved on: 
Tuesday, September 6, 2022

PORTLAND, Ore., Sept. 6, 2022 /PRNewswire/ -- The FinOps Foundation, a part of The Linux Foundation's non-profit technology consortium focused on advancing the people and practice of cloud financial management, announced today that insurance giant, AIA Group, is joining as a Premier Member company.

Key Points: 
  • As part of AIA's Premier Membership, Keith Austin, Associate Director of Cloud Services, leading the Cloud Centre of Excellence at AIA, will join the FinOps Governing Board as a voting member to help craft Foundation strategy and direction.
  • FinOps is now practiced in every major industry and AIA will lead the early growth of FinOps in the Asia-Pacific region, which is following North America and Europe in FinOps adoption, research shows.
  • This will now include the FinOps Foundation," saidMarcel Malan, AIA Group's Head of Group IT Operations.
  • "AIA's rapid cloud adoption takes courage, leadership and a committed team and partnership," said J.R. Storment, Executive Director of the FinOps Foundation.

VerImmune and Fosun Pharma enter into an Exclusive License and Option Agreement for VerImmune's Virus-inspired Particle (ViP) platform as Novel Immunotherapies in China

Retrieved on: 
Friday, May 20, 2022

WASHINGTON, May 20, 2022 /PRNewswire-PRWeb/ -- VerImmune Inc. ("VerImmune"), a privately-held biotechnology company developing a novel therapeutic virus-inspired particle (ViP) modality that redirects the body's pre-existing immunity against viral pathogens to attack cancer, and Fosun Pharma USA, the US based subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma"), a leading global pharmaceutical and healthcare provider headquartered in China, announced today that the companies have entered into an Exclusive License and Option agreement effective May 18th,2022.

Key Points: 
  • VerImmune is also eligible for significant additional milestone payments and tiered royalties subject to Fosun Pharma's exercise of its option to select other AIR-ViP product candidates.
  • Fosun Pharma will be responsible for all clinical development and commercialization in these territories.
  • Building upon this highly adaptable ViP platform, VerImmune has developed a First-in-Class novel therapeutic strategy called "Anti-tumor Immune Redirection" (AIR).
  • Fosun Pharma also vigorously explores cutting-edge technologies, such as RNA, oncolytic viruses, gene therapy and PROTAC, to enhance its innovation capabilities.

MHI Receives Contract for Extensions to the Macau LRT Network Using an AGT System

Retrieved on: 
Thursday, April 14, 2022

- MHI to handle entire system except for construction of station buildings, civil engineering work, and rolling stock.

Key Points: 
  • - MHI to handle entire system except for construction of station buildings, civil engineering work, and rolling stock.
  • TOKYO, Apr 14, 2022 - (JCN Newswire) - Mitsubishi Heavy Industries, Ltd. (MHI) has received an order from the Infrastructure Development Office (GDI) of the Macau Special Administrative Region in China for extensions of the Macau Light Rapid Transit(1) (MLRT) network using an Automated Guideway Transit(2) (AGT) system.
  • MHI will make use of the accumulated knowledge of MHI Group, focusing its efforts on strengthening the system for safe and smooth transport in the Macau metropolitan area.
  • This project comprises three new extensions from the Taipa Line (11 stations, 9.3km) currently operating on the Taipa island area of Macau, a district lined with new resort hotels.